Why the study?
Does coadministration of simvastatin or lovastatin increase dabigatran exposure or major hemorrhage risk in patients taking dabigatran for atrial fibrillation?
Does coadministration of simvastatin or lovastatin increase dabigatran exposure or major hemorrhage risk in patients taking dabigatran for atrial fibrillation?
Answers are grounded in this paper and cite their sources.
This letter to the editor challenges prior observational findings by arguing that pharmacokinetic and clinical data do not support an increased bleeding risk when dabigatran is coadministered with simvastatin or lovastatin.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Haertter et al. (2017) conducted a letter in Atrial fibrillation. Dabigatran etexilate coadministered with simvastatin or lovastatin vs. Dabigatran etexilate coadministered with other statins was evaluated on Major hemorrhage or dabigatran exposure.
Synapse has enriched 10 related papers. Consider them for comparative context: